BC
FSTX

Boxer Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Boxer Capital’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,751,428
Closed -$12.8M – 93
2021
Q3 		$12.8M Hold
1,751,428
– – 0.45% 56
2021
Q2 		$15M Buy
+1,751,428
New +$14.9M 0.53% 56

Other funds holding FSTX

RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boxer Capital's FSTX Position: Q4 2021 in Review

Boxer Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2021, closing a stake of 1,751,428 shares — an estimated $12.8M sold.

Boxer Capital first reported a position in FSTX in Q2 2021 and held it in 2 quarters. The position peaked at $15M in Q2 2021. 43 funds tracked by Wall St. Rank hold FSTX as of Q4 2021.

  • Boxer Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Boxer Capital sold 1,751,428 F-star Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $12.8M.
  • Boxer Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Boxer Capital's F-star Therapeutics, Inc. Common Stock position peaked at $15M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Boxer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.